NO20035566L - Prebiotiske kombinasjonsprodukter - Google Patents

Prebiotiske kombinasjonsprodukter

Info

Publication number
NO20035566L
NO20035566L NO20035566A NO20035566A NO20035566L NO 20035566 L NO20035566 L NO 20035566L NO 20035566 A NO20035566 A NO 20035566A NO 20035566 A NO20035566 A NO 20035566A NO 20035566 L NO20035566 L NO 20035566L
Authority
NO
Norway
Prior art keywords
prebiotic
prophylaxis
small amount
combination products
prebiotic combination
Prior art date
Application number
NO20035566A
Other languages
English (en)
Other versions
NO20035566D0 (no
NO320546B1 (no
Inventor
Jan Yngvar Piene
Original Assignee
Nova Biotics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nova Biotics As filed Critical Nova Biotics As
Priority to NO20035566A priority Critical patent/NO320546B1/no
Publication of NO20035566D0 publication Critical patent/NO20035566D0/no
Priority to AT04808876T priority patent/ATE424832T1/de
Priority to DE602004019968T priority patent/DE602004019968D1/de
Priority to EP04808876A priority patent/EP1696937B1/en
Priority to PCT/NO2004/000382 priority patent/WO2005056023A1/en
Publication of NO20035566L publication Critical patent/NO20035566L/no
Publication of NO320546B1 publication Critical patent/NO320546B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20035566A 2003-12-12 2003-12-12 Prebiotiske kombinasjonsprodukter NO320546B1 (no)

Priority Applications (5)

Application Number Priority Date Filing Date Title
NO20035566A NO320546B1 (no) 2003-12-12 2003-12-12 Prebiotiske kombinasjonsprodukter
AT04808876T ATE424832T1 (de) 2003-12-12 2004-12-10 Präbiotische kombinationsprodukte
DE602004019968T DE602004019968D1 (de) 2003-12-12 2004-12-10 Präbiotische kombinationsprodukte
EP04808876A EP1696937B1 (en) 2003-12-12 2004-12-10 Prebiotic combination products
PCT/NO2004/000382 WO2005056023A1 (en) 2003-12-12 2004-12-10 Prebiotic combination products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20035566A NO320546B1 (no) 2003-12-12 2003-12-12 Prebiotiske kombinasjonsprodukter

Publications (3)

Publication Number Publication Date
NO20035566D0 NO20035566D0 (no) 2003-12-12
NO20035566L true NO20035566L (no) 2005-06-13
NO320546B1 NO320546B1 (no) 2005-12-19

Family

ID=30439651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035566A NO320546B1 (no) 2003-12-12 2003-12-12 Prebiotiske kombinasjonsprodukter

Country Status (5)

Country Link
EP (1) EP1696937B1 (no)
AT (1) ATE424832T1 (no)
DE (1) DE602004019968D1 (no)
NO (1) NO320546B1 (no)
WO (1) WO2005056023A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007050656A2 (en) 2005-10-24 2007-05-03 Nestec S.A. Dietary fiber formulation and method of administration
PL2561766T3 (pl) 2006-11-07 2018-06-29 The Procter And Gamble Company Kompozycje zawierające błonnik oraz sposoby ich wytwarzania i stosowania
US20080254166A1 (en) * 2007-01-25 2008-10-16 Potter Susan M Food Additives Containing Combinations of Prebiotics and Probiotics
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
DE102008059070B4 (de) 2008-11-26 2019-05-16 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur therapeutischen oder prophylaktischen Behandlung von Durchfallerkrankungen und/oder zur Aufrechterhaltung und/oder Wiederherstellung der natürlichen Darmflora, Dosiereinheit, Verpackungseinheit und Verwendung der Zusammensetzung
EP2216036A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
GB0907019D0 (en) * 2009-04-24 2009-06-03 Oxford Nutrascience Ltd Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
DE102011012494A1 (de) 2011-02-25 2012-08-30 Humana Milchunion Eg Prebiotische Kohlenhydrat-Zusammensetzungen
US10117885B2 (en) 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
US11253531B2 (en) 2011-08-11 2022-02-22 Nutritional Therapeutics, Inc. Lipid supplements for reducing nerve action potentials
WO2015169816A1 (en) 2014-05-05 2015-11-12 Basf Se Formulation of fat-soluble vitamin
US20170042950A1 (en) * 2015-08-11 2017-02-16 Shaklee Corporation Materials and methods for improving gastrointestinal health
US20190275076A1 (en) * 2018-03-08 2019-09-12 Coöperatie Koninklijke Cosun U.A. Dietary fiber compositions for curative or prophylactic treatment of obesity and other conditions
EP3556226B1 (de) * 2018-04-20 2021-01-20 Raab Vitalfood GmbH Komplex-synbiotikum zum aufbau einer gesunden darmflora
WO2019237152A1 (en) * 2018-06-15 2019-12-19 University Of Tasmania Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane
RU2713154C1 (ru) * 2018-10-04 2020-02-04 Игорь Юрьевич Чичерин Антихеликобактерное средство и способ его применения
CN110652009B (zh) * 2019-10-23 2023-03-17 四川拜奥德克生物科技有限公司 一种高纤维膳食补充剂用于预防及改善骨代谢相关疾病的新用途
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69506095T2 (de) * 1995-08-04 1999-06-24 Nutricia Nv Diätfasern enthaltende Nahrungszusammensetzung
DK0869775T3 (da) * 1995-12-26 2009-07-27 Cns Inc Afgivesystem til inulinkostfibre
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6436446B1 (en) * 1999-07-30 2002-08-20 Pharmavite Llc Composition for increasing bone density
AU2001231746C1 (en) * 2000-03-01 2005-10-06 Societe Des Produits Nestle S.A. Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
EP1175905A1 (en) * 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Nutritional Composition
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
EP1386546A1 (en) * 2002-07-31 2004-02-04 Ca.Di.Group S.r.l. Association of prebiotics and colonic foods intended to help and keep the physiological health and the functional capacity of the intestine

Also Published As

Publication number Publication date
EP1696937A1 (en) 2006-09-06
DE602004019968D1 (de) 2009-04-23
NO20035566D0 (no) 2003-12-12
EP1696937B1 (en) 2009-03-11
NO320546B1 (no) 2005-12-19
WO2005056023A1 (en) 2005-06-23
ATE424832T1 (de) 2009-03-15

Similar Documents

Publication Publication Date Title
ATE424832T1 (de) Präbiotische kombinationsprodukte
EP2277512A3 (en) Pharmaceutical compositions and dosage forms of thalidomide
Yoshida et al. Correlation between dental and nutritional status in community‐dwelling elderly Japanese
CY1116093T1 (el) Χρηση νιντεντανιμπης για την αγωγη της πνευμονικης ινωσεως
EA200600041A1 (ru) Применение изомальта (смеси 1,6-gps и 1,1-gpm) в качестве пребиотика, в частности, для получения лекарственного средства для лечения кишечных заболеваний
MXPA05009595A (es) Compuestos 7-amino-isoindolilo y sus usos farmaceuticos.
MX2009003305A (es) Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso.
TW200621317A (en) Pharmaceutical composition
IL180979A (en) Isoindulin compounds and their use
DK1841332T3 (da) Fortykningskomposition til dysfagi patienter
EA200900044A1 (ru) Замещенные производные 1,3-дифенилпропана, получение и их применение
BRPI0615989B8 (pt) formulação farmacêutica de dosagem oral
TW200738269A (en) Oral delivery of therapeutic agents using tight junction agonists
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
ES2525931T3 (es) Composiciones y métodos para prevenir o tratar enfermedad inflamatoria intestinal
MX2010007033A (es) Compuestos para el tratamiento selectivo del componente inmunoinflamatorio intestinal de la enfermedad celiaca.
AR013739A1 (es) Composiciones de agentes reductores de lipidos
EA201000854A1 (ru) Применение эдта и ее солей для профилактики и лечения дизентерии свиней и усиления эффектов антибиотиков, проявляющихся при этом заболевании
RS20060662A (en) 4-phenyl-pyrimidine-2-carbonitrile derivatives
BRPI0504758A (pt) miméticos de interleucina-8 e métodos para usá-los em prevenção, tratamento, diagnóstico, e melhora dos sintomas de uma doença
CL2008003438A1 (es) Producto liquido nutricional de administracion oral que comprende un antagonista del receptor vanilloide 1 (vr-1) y su uso para tratar la disfagia oral faringea.
MX2009010763A (es) NUEVO REGIMEN DE DROSPIRENONA/17ß-ESTRADIOL, PRODUCTO FARMACEUTICO COMBINADO Y CONJUNTO DE ELEMENTOS (KIT) PARA SU APLICACION.
HRP20161166T1 (hr) Tapentadol za uporabu u liječenju sindroma iritabilnog crijeva
AR065918A1 (es) Composiciones farmaceuticas sinergicas que comprenden la combinacion de un inhibidor de la enzina 5 alfa-reductasa y un antagonista de los receptores 1-adrenergicos
FR2834641B1 (fr) Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: JAN YNGVAR PIENE, UNDELSTAD TERRASSE 25 B, 1387 AS

MM1K Lapsed by not paying the annual fees